f Therapeutic Benefits of Bioactive Compounds in Brain Disorders

References

1. ErdmanJ.W. Health and nutrition beyond essential nutrients: The evolution of the bioactives concept for human health.Mol. Aspects Med.20238910111610.1016/j.mam.2022.101116 35965134
   [Google Scholar]
2. Garza-JuárezA. Pérez-CarrilloE. Arredondo-EspinozaE.U. IslasJ.F. Benítez-ChaoD.F. Escamilla-GarcíaE. Nutraceuticals and their contribution to preventing noncommunicable diseases.Foods20231217326210.3390/foods12173262 37685194
   [Google Scholar]
3. MiloševićM. ArsićA. CvetkovićZ. VučićV. Memorable food: Fighting age-related neurodegeneration by precision nutrition.Front. Nutr.2021868808610.3389/fnut.2021.688086 34422879
   [Google Scholar]
4. ZupoR. CastellanaF. PanzaF. SolfrizziV. LozuponeM. TardugnoR. CiceroN. CorboF. CrupiP. SardoneR. ClodoveoM.L. Alzheimer’s disease may benefit from olive oil polyphenols: A systematic review on preclinical evidence supporting the effect of oleocanthal on amyloid-β load.Curr. Neuropharmacol.202523101249125910.2174/011570159X327650241021115228 39482909
   [Google Scholar]
5. PatockaJ. SharmaS. NavratilovaZ. SinghN. JelinkovaR. MehboobN. OleksakP. NepovimovaE. KucaK. Anticholinesterases traits inbuilt in buxaceae plant extracts against Alzheimer’s disease.Curr. Neuropharmacol.202523101137115510.2174/1570159X23666250326091016 40207817
   [Google Scholar]
6. ZiaB. ElmekyM. AzimullahS. JhaN.K. MeeranM.F.N. OjhaS.K. The multifaceted role of neuroprotectin D1: Physiological, pathophysiological, and pharmacological insights in neurodegenerative diseases.Curr. Neuropharmacol.202523101215123110.2174/011570159X365720250225080257 40197185
   [Google Scholar]
7. PiccirilloS. PreziusoA. TizianoS. CerqueniG. TerenziV. LaricciaV. MagiS. Unveiling the potential neuroprotective effect of bioactive compounds from plants with sedative and mood-modulating properties: Innovative approaches for the prevention of Alzheimer’s and Parkinson’s diseases.Curr. Neuropharmacol.202523101169118310.2174/011570159X345397241210103538 39950483
   [Google Scholar]
8. StrilbytskaO. KoliadaO. LushchakV. LushchakO. The effects of bioactive compounds on PTSD treatment.Curr. Neuropharmacol.202523101156116810.2174/011570159X333438240927103741 39354772
   [Google Scholar]
9. TianS.Y. CaoX. LiuG.J. ZiY. ZhuH.X. JiangY.M. LouW.W. FangX.X. ShanL. LiuZ. ZhuangQ.X. Role of the central cholinergic nervous system in motor and non-motor symptoms of Parkinson’s disease.Curr. Neuropharmacol.202523101232124810.2174/011570159X368923250313045859 40108903
   [Google Scholar]
10. KalininA.P. ZubkovaE.S. MenshikovM.Y. ParfyonovaY.V. ISR modulators in neurological diseases.Curr. Neuropharmacol.202523101184121410.2174/011570159X361653250213114821 39995125
    [Google Scholar]